Search Results for 'bevacizumab'

bevacizumab published presentations and documents on DocSlides.

Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay o

Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay o

by genderadidas

. Boris . Winterhoff. , MD, MS. 1,11,12. , . Ste...

Pathophysiology of diabetic retinopathy and diabetic macular edema

Pathophysiology of diabetic retinopathy and diabetic macular edema

by jane-oiler

Charles C. Wykoff, MD, PhD, FACS. Physician, Reti...

Antiangiogenic Agents in Advanced NSCLC

Antiangiogenic Agents in Advanced NSCLC

by ellena-manuel

Jared Weiss, MD . Assistant . Professor of Medici...

Corneal fine needle diathermy with adjuvant

Corneal fine needle diathermy with adjuvant

by myesha-ticknor

bevacizumab. to treat corneal neovascularization...

Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t

Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t

by sherrill-nordquist

Yes . Deborah . Schrag. , MD, MPH. No. John L. Ma...

Please note, these are the actual video-recorded proceeding

Please note, these are the actual video-recorded proceeding

by lindy-dunigan

Moderator. Neil Love, MD. Jessica Mitchell, RN, C...

Please note, these are the actual video-recorded proceeding

Please note, these are the actual video-recorded proceeding

by debby-jeon

Year in Review 2012. Colorectal Cancer. Daniel G ...

Part B Medical Drugs Requiring Step

Part B Medical Drugs Requiring Step

by udeline

-TherapyDrug subject to Step TherapyTry these Opti...

Diabetic Retinopathy Clinical Research Network

Diabetic Retinopathy Clinical Research Network

by classyshadow

Comparative Effectiveness of Aflibercept, Bevacizu...

Bradley J. Monk, M.D.

Bradley J. Monk, M.D.

by tawny-fly

Professor and Director. Division of Gynecologic O...

1. In general, when do you typically order mutation testing for your patients with newly diagnosed

1. In general, when do you typically order mutation testing for your patients with newly diagnosed

by opelogen

At initial diagnosis . 0. At first relapse . 0. At...

What’s Positive about Triple Negative Breast Cancer

What’s Positive about Triple Negative Breast Cancer

by myesha-ticknor

What’s Positive about Triple Negative Breast Ca...

The Role of Antiangiogenic Agents

The Role of Antiangiogenic Agents

by luanne-stotts

The Role of Antiangiogenic Agents in the Changin...

As it pertains to the last patient in your practice who died of metastatic nonsquamous

As it pertains to the last patient in your practice who died of metastatic nonsquamous

by kittie-lecroy

non-small cell lung cancer (NSCLC) . with no targ...

Shin-Ichi Miyatake,

　　 Shin-Ichi Miyatake,

by aaron

MD., Ph.D.. Shinji Kawabata, Motomasa . Furuse. ...

Challenges in RAS Wild-Type mCRC

Challenges in RAS Wild-Type mCRC

by marina-yarberry

Introduction. Decision-Making Algorithm for First...

A MARKOV DECISION TREE MODEL

A MARKOV DECISION TREE MODEL

by natalia-silvester

TO EVALUATE COST-EFFECTIVENESS. OF CERVICAL CANCE...

Carcinosi peritoneale sincrona da carcinoma colorettale: ci

Carcinosi peritoneale sincrona da carcinoma colorettale: ci

by calandra-battersby

Quale chemioterapia sistemica?. Dott. Giuseppe Co...

Using Non-targeted Therapies in Targeted Lung Cancer Popula

Using Non-targeted Therapies in Targeted Lung Cancer Popula

by ellena-manuel

Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...

Colorectal Cancer

Colorectal Cancer

by liane-varnes

Laura . Bidstrup. Mr A is a 39 . yo. . man who a...

ASCO Update 2012:

ASCO Update 2012:

by tatyana-admore

Gastrointestinal Malignancies. Thomas J. Semrad M...

CODE: TCS/16/31 RESEARCH

CODE: TCS/16/31 RESEARCH

by jewelupper

PROJECT. . BRIEFING. KEY. . FINDINGS. In the ver...

Please note, these are the

Please note, these are the

by markes

actual. . video-recorded proceedings from the . l...

Colorectal Cancer

Colorectal Cancer

by haroublo

Bidstrup. Mr A is a 39 . yo. . man who attended f...

Colorectal Cancer

Colorectal Cancer

by southan

Bidstrup. Mr A is a 39 . yo. . man who attended f...

METASTASES HEPATIQUES CRC :point de vue de l’ oncologue

METASTASES HEPATIQUES CRC :point de vue de l’ oncologue

by jiggyhuman

F DESSEIGNE TANGER 27 04 2018. Phase III First-Lin...

Ovarian Cancer: Standards of Care and New Opportunities

Ovarian Cancer: Standards of Care and New Opportunities

by majerepr

Robert L. Coleman, M.D.. Professor & . Vice Ch...

Part B Medical Drugs Requiring StepTherapy

Part B Medical Drugs Requiring StepTherapy

by natalie

Drug subject to Step Therapy BRAND NAME GENERIC NA...

Immunotherapy for advanced cervical cancer

Immunotherapy for advanced cervical cancer

by elizabeth

Megan Swanson, MD MPH. Assistant Professor. Gyneco...

TheAgeRelatedEyeDiseaseStudyAREDSprovidedthebestevidenceforantioxida

TheAgeRelatedEyeDiseaseStudyAREDSprovidedthebestevidenceforantioxida

by layla

1–2 1 InitiallystudiesofVEGFhaveprimarilycen...

8Wagner S WarmuthMetz M Emser A Treatment options9Wolff JE Molen

8Wagner S WarmuthMetz M Emser A Treatment options9Wolff JE Molen

by brown

2269 patients as an antiangiogenic agent (16). The...

Inaugural Recurrent Respiratory

Inaugural Recurrent Respiratory

by deborah

Papillomatosis Roundtable. Executive Summary. Tabl...

Treatment in Advanced Non-Small Cell Lung Cancer

Treatment in Advanced Non-Small Cell Lung Cancer

by oconnor

. 5. th. most commonly diagnosed cancer in Austra...

CERVICAL CARCINOMA Dr Shanzah Shahbaz

CERVICAL CARCINOMA Dr Shanzah Shahbaz

by ceila

Consultant Medical . Oncologist. BEFORE START OF T...